Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials

被引：20

作者：

Zamagni, Elena ^{[1
]}

Nanni, Cristina ^{[2
]}

Dozza, Luca ^{[1
]}

Carlier, Thomas ^{[3
,4
]}

Tacchetti, Paola ^{[1
]}

Versari, Annibale ^{[5
]}

Chauvie, Stephane ^{[6
]}

Gallamini, Andrea ^{[7
]}

Attal, Michel ^{[8
]}

Gamberi, Barbara ^{[9
]}

Caillot, Denis ^{[10
]}

Patriarca, Francesca ^{[11
]}

Macro, Margaret ^{[12
]}

Boccadoro, Mario ^{[13
]}

Garderet, Laurent ^{[14
,15
]}

Fanti, Stefano ^{[2
]}

Perrot, Aurore ^{[16
]}

Gay, Francesca ^{[17
]}

Sonneveld, Pieter ^{[18
]}

Karlin, Lionel ^{[19
]}

Cavo, Michele ^{[1
]}

Bodet-Milin, Caroline ^{[3
,4
]}

Moreau, Philippe ^{[20
]}

Kraeber-Bodere, Francoise ^{[3
,4
]}

机构：

[1] Univ Bologna, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[2] St Orsola Malpighi Hosp, Nucl Med Unit, Bologna, Italy

[3] Nantes Univ Hosp, Nucl Med Dept, Nantes, France

[4] INSERM, CRCINA, UMR 1232, Nantes, France

[5] AO Arcispedale S Maria Nuova, SC Med Nucl Ctr PET, Reggio Emilia, Italy

[6] Santa Croce & Carle Hosp, Med Phys Unit, Cuneo, Italy

[7] Antoine Lacassagne Canc Ctr, Res Innovat & Stat, Nice, France

[8] Univ Hosp, Hematol Dept, Toulouse, France

[9] Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

[10] Univ Hosp Dijon, Dept Hematol, Dijon, France

[11] Univ Udine, Hematol & Bone Marrow Transplant Unit, Udine, Italy

[12] Caen Univ Hosp, Haematol Dept, Caen, France

[13] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Hematol Div, Turin, Italy

[14] Hop St Antoine, Paris, France

[15] Univ Hosp St Antoine, Hematol Dept, Dijon, France

[16] Univ Lorraine, Nancy, France

[17] Univ Torino, Div Hematol, Myeloma Unit, Turin, Italy

[18] Erasmus MC, Dept Hematol, Rotterdam, Netherlands

[19] Univ Claude Bernard, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France

[20] Nantes Univ Hosp, Nantes, France

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-111321

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

257

引用

页数：4

共 50 条

[41] 18F-FDG PET/CT of extramedullary disease in newly diagnosed multiple myeloma: imaging findings and its correlation with clinical indicators and outcome
Zhao, Yunyun
Wang, Qian
JOURNAL OF NUCLEAR MEDICINE, 2020, 61
[42] Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma
Marchiori, Silvano
Cousin, Francois
Papadopoulos, Iraklis
Bernard, Claire
Thys, Marie
De Prijck, Bernard
Pirotte, Michelle
Donneau, Anne-Francoise
Hustinx, Roland
Caers, Jo
Withofs, Nadia
EJNMMI RESEARCH, 2024, 14 (01):
[43] Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myeloma
Abe, Yoshiaki
Narita, Kentaro
Kobayashi, Hiroki
Kitadate, Akihiro
Miura, Daisuke
Takeuchi, Masami
O'uchi, Eri
O'uchi, Toshihiro
Matsue, Kosei
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (06) : 1325 - 1333
[44] Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myeloma
Yoshiaki Abe
Kentaro Narita
Hiroki Kobayashi
Akihiro Kitadate
Daisuke Miura
Masami Takeuchi
Eri O’uchi
Toshihiro O’uchi
Kosei Matsue
European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1325 - 1333
[45] Value of 18F-FDG PET/CT in patients with newly diagnosed multiple myeloma:: Comparison with whole body X-ray in the assessment of bone involvement
Myslivecek, M.
Bacovsky, J.
Buriankova, E.
Koranda, P.
Formanek, R.
Kaminek, M.
Scudla, V.
Ptacek, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S236 - S236
[46] Implications of 18F-FDG PET/CT findings before autologous stem cell transplant in patients with multiple myeloma.
Khan, Muhammad Azeem
Markabawi, Danny
Alberti, Matthew
Burton, Jeffrey
Maini, Ruby
Catalfamo, Vince
Badari, Ambuga
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[47] The Diagnostic and Prognostic Utility of 18F-FDG PET/CT in Transplant Ineligible Multiple Myeloma Patients Receiving Novel Agents
Takeoka, Yasunobu
Yamamura, Ryosuke
Araki, Taku
Inaba, Akiko
Fujitani, Yotaro
Koh, Genju
Seura, Hirotaka
Okamura, Terue
Ohta, Kensuke
BLOOD, 2013, 122 (21)
[48] Induction regimens for transplant-eligible patients with newly diagnosed multiple myeloma: a network meta-analysis of randomized controlled trials
Zeng, Zi-Hang
Chen, Jia-Feng
Li, Yi-Xuan
Zhang, Ran
Xiao, Ling-Fei
Meng, Xiang-Yu
CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 287 - 298
[49] Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
Pan, Qingqing
Cao, Xinxin
Luo, Yaping
Li, Jian
Feng, Jun
Li, Fan
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 537 - 546
[50] Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
Qingqing Pan
Xinxin Cao
Yaping Luo
Jian Li
Jun Feng
Fang Li
European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 537 - 546

← 1 2 3 4 5 →